Pharma Journalist -

Editas Medicine, Inc. a leading genome editing company, announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to EDIT-301, an investigational, gene…
Read More...

The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic…
Read More...

Neurocrine Biosciences, Inc. announced that it has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for valbenazine as a treatment for Huntington…
Read More...

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial…
Read More...

Mindset Pharma Inc. a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric…
Read More...

Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated pathologies, announces the close of a $26 million financing round…
Read More...

Nuvig Therapeutics, Inc., announced the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without…
Read More...

Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) has approved OLUMIANT (baricitinib) for the treatment of COVID-19 in hospitalized adults requiring…
Read More...

Neuvivo, a biopharmaceutical company dedicated to delivering an effective, safe ALS treatment to patients, announced that it has initiated cGMP manufacturing of NP001 for the treatment…
Read More...

Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that is has received a $1.1M supplement to its $3.1M National Center for Advancing Translational Sciences (NCATS) Award,…
Read More...